Russia Wants To Release A Cure For Coronavirus Without Permission

Russia Wants To Release A Cure For Coronavirus Without Permission
Russia Wants To Release A Cure For Coronavirus Without Permission

Video: Russia Wants To Release A Cure For Coronavirus Without Permission

Video: Covid-19: what’s really going on in Russia? | The Economist 2022, November
Anonim

The head of the Pharmasintez company, Vikram Punia, wants to obtain permission to release the medicine for the coronavirus remdesivir without permission from the patent owner. The businessman sent a letter to the head of the presidential administration Anton Vaino and Deputy Prime Minister Tatyana Golikova. The patent for remdesivir belongs to the American company Gilead Sciences. She developed the drug and produces it under the Vekluri brand. Pharmasintez has developed an analogue of remdesivir - remdeform. However, the firm cannot release a generic drug because of the Gilead Sciences patent. The American company did not respond to a request to start negotiations, but voluntarily granted a license to 127 countries - Russia is not among them. Punia suggested that officials apply the compulsory licensing procedure - in Russia it has never been activated yet. The businessman added that a five-day course of Vekluri costs $ 2340, and a generic drug would help reduce the cost of treatment. As of November 2, more than 1.655 million cases of COVID-19 have been registered in Russia. Over the past day, the diagnosis was confirmed in 18,257 people. Since the beginning of the pandemic, 1.236 million patients have recovered, 28,473 have died. Earlier, the World Health Organization (WHO) recognized remdesivir as ineffective in treating coronavirus. Neither this drug nor the three others (hydroxychlorine, lopinavir, and interferon) reduced patients' ventilation requirements. Photo: Pixabay, Pixabay License Firm Sekret has a Telegram channel. Subscribe!

Image
Image

Popular by topic